An observational study in Intraocular Lens Complication, Intraocular Lens Rotation and Intraocular Lens Associated Postoperative Inflammation, sponsored by University Hospital Augsburg. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-05.
Sponsored by University Hospital Augsburg · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 61 studies in Cataract with a site in Germany — 8 open to participants now, 11 under way, none of them phase 3. Cataract · Germany.
Among the 61 studies in Cataract with a site in Germany, this one is the 2nd largest by planned enrollment of the 11 observational ones that give a count, is one of 2 that started in 2024, is one of 11 observational ones, reaches primary completion later than 10 of the 10 other live ones, and was the 55th registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →8 of the 61 studies in Cataract with a site in Germany are open now. Recruiting first, the newest first:
Carl Zeiss Meditec AG · Sites in Germany, Czechia, Spain and 1 more country
Ages 18+
University of Cologne · Sites in Germany, Denmark, Netherlands and 1 more country
Ages 18+
Xi'an Eyedeal Medical Technology Co., Ltd · Sites in Germany, Lithuania
Ages 22+
Hanita Lenses · Sites in Germany
Ages 18+
Cristalens Industrie · Sites in Germany
Ages 50–85
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
61 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 90 across 477 observational studies indexed under Cataract.
Median enrollment 95 across the 50 interventional studies, 242 across the 11 observational. Of the 47 that completed or were terminated, 6 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
48 of 61 have an industry lead sponsor. The 10 most frequent:
University Hospital Augsburg is the lead sponsor of 25 studies on the registry; 18 are open to participants now.
University Hospital Augsburg has 1 study filed under Cataract — fewer than ten, so there is no comparison to draw.
1 of the studies in Cataract with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07232615Biotech Healthcare Holding GmbhA Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses Used in Cataract Surgery | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 61 studies in Cataract with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this registry study is to optimize the results with intraocular lens implants used in cataract surgery.
A variety of intraocular lens implants are available for patients undergoing cataract surgery and new technologies are continuously being developed in this field.
In the planned monocentric retro- and prospective clinical study, a database to optimize outcomes with modern intraocular lens implants will be established to further improve anatomical and functional outcomes.
Patients treated with an intraocular lens implant will be included. The retrospective evaluation of data includes data routinely collected prior to study inclusion (preoperative, intraoperative, postoperative up to the 1st study visit). Prospectively, refraction, visual acuity, examination findings, intraocular pressure and complications are recorded 1-6 months postoperatively. Depending on the type of IOL, results of further non-invasive measurements are also recorded. Optional follow-up visits with the aforementioned examinations are possible up to 10 years postoperatively.
Patients who receive an intraocular lens are offered to participate in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Treatment with an intraocular lens implant 18 years of age or older Patient consent Full legal capacity
Exclusion Criteria:
Dementia Pregnancy Breastfeeding
Intraocular lenses are implanted during cataract surgery to replace the human crystalline lens.
Functional results with different Intraocular lenses
Visual acuity with different intraocular lenses is determined.
Time frame: 6 months
Contrast sestivitiy with different Intraocular lenses
Contrast sensitivity with different intraocular lenses is determined.
Time frame: 6 months
Anatomical results.
Anatomical results with different intraocular lenses are determined.
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Feb 2029, 59 months after the start.
Of 169 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's planned 59 months is above that.
Counting every sponsor, half of 236 studies reached it within 16 months; a quarter within 9 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Augsburg